InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Dearen Danny L., 管理人员. Director active across 3 companies, notably Axonics, Inc.. Aggregated, 20 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.5m. History available since 20 May 2021. The latest transaction was filed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Dearen Danny L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
16,965 股0Common StockSEC:0001756438-26-000003:0
44,030 股0Common StockSEC:0001493152-26-002664:0
3,997 股0Common StockSEC:0001756438-26-000002:0
11,247 股0Common StockSEC:0001415889-25-008535:0
36,919 股0Common StockSEC:0001562180-23-007189:0
11,250 股0Common StockSEC:0001562180-23-007190:0
7,699 股@ US$49.43559.7% 占其流量Common StockSEC:0001562180-23-004641:0
13,208 股@ US$14.194.7% 占其流量Common StockSEC:0001562180-23-003685:0
10,363 股@ US$59.930815.5% 占其流量Common StockSEC:0001562180-23-003685:1
9,637 股@ US$60.503714.6% 占其流量Common StockSEC:0001562180-23-003685:2
2,001 股@ US$14.190.7% 占其流量Common StockSEC:0001562180-23-003669:0
6,633 股@ US$14.192.4% 占其流量Common StockSEC:0001562180-23-003425:0
5,000 股0Common StockSEC:0001562180-23-000874:0
656 股@ US$75.601.4% 占其流量Common StockSEC:0001562180-22-006685:0
1,616 股@ US$1.320.1% 占其流量Common StockSEC:0001562180-22-006102:0
12,329 股@ US$25.8215.2% 占其流量Common StockSEC:0001562180-22-002348:0
6,421 股@ US$25.825.0% 占其流量Common StockSEC:0001562180-22-002063:0
20,000 股@ US$14.198.6% 占其流量Common StockSEC:0001562180-22-001105:0
10,805 股@ US$14.194.6% 占其流量Common StockSEC:0001562180-22-000563:0
28,291 股@ US$14.1911.2% 占其流量Common StockSEC:0001562180-21-003716:0
20 条申报中的 20 条
About Dearen Danny L.
Dearen Danny L. is an executive linked to Axonics, Inc., where he is President & CFO, and a director of Beta Bionics, Inc. and InspireMD, Inc. He has 20 filings in total, and within the recent filings covered here, sell transactions amount to EUR 1502148, with activity ranging from 2021-05-24 to 2026-05-26, and the most common transaction nature being option exercise.
